PFIZER INC Operating Leases, Future Minimum Payments, Due in Four Years
PFIZER INC (PFE) had Operating Leases, Future Minimum Payments, Due in Four Years of $267.00 million as of 2018-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-02-27
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $267.00M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $136.00M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $138.00M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $143.00M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $267.00M 10-K · filed 2020-02-27 |
| 2017-12-31 | $136.00M 10-K · filed 2018-02-22 |
| 2016-12-31 | $138.00M 10-K · filed 2017-02-23 |
| 2015-12-31 | $143.00M 10-K · filed 2016-02-29 |
| 2014-12-31 | $112.00M 10-K · filed 2015-02-27 |
| 2013-12-31 | $98.00M 10-K · filed 2014-02-28 |
| 2012-12-31 | $85.00M 10-K · filed 2013-02-28 |
| 2011-12-31 | $105.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |